Business Wire

Simpson Thacher Adds Leading Antitrust and Competition Lawyer Antonio Bavasso

15.12.2020 11:00:00 EET | Business Wire | Press release

Share

Simpson Thacher & Bartlett LLP announced today that Antonio Bavasso will join the Firm’s London office, where he will be a Partner in the Antitrust and Trade Regulation Practice.

Antonio is widely recognized as a leading lawyer in antitrust and regulation, with more than twenty years of experience in some of the most high-profile and precedent-setting merger, behavioural and litigation cases internationally. He advises clients across a broad range of industries, including the technology, media and telecom sectors, in a wide variety of matters before the European Commission, the United Kingdom Competition and Markets Authority and other global competition authorities.

“Antonio has extensive experience that is relevant to our clients, having advised on the antitrust aspects of some of the most high-profile transactions in recent years. That experience will further enhance our ability to provide clients operating across Europe with top-tier advice in both tackling complex transactions and in navigating the enforcement landscape,” said Bill Dougherty, Chairman of Simpson Thacher’s Executive Committee. “We are very pleased to welcome him to the Firm.”

Simpson Thacher’s Antitrust and Trade Regulation Practice advises companies across every major industry on their global antitrust and competition needs, as well as on regulatory issues impacting their interests and operations around the world. The Firm counsels clients on the full array of antitrust enforcement, litigation and investigation issues—from cartel and other anticompetitive activity to litigation of private antitrust actions—as well as regulatory and compliance matters related to cross-border activities such as trade regulation and economic sanctions.

“Antonio is known throughout the market for his superb judgment and ability to provide clients with insightful and practical advice on high-profile, cross-border transactions, as well as in complex antitrust litigation and enforcement matters. This diversity of experience makes him a natural fit for Simpson Thacher and a wonderful addition to both our global M&A and Antitrust and Trade Regulation Practices, and sets the stage for the further expansion of our European antitrust and competition practice,” said David Vann, Head of Antitrust for Europe and Asia at Simpson Thacher.

“Given the sophistication and versatility of his experience, Antonio will deliver tremendous value to our clients and is an excellent addition to our outstanding group of lawyers in London,” added Jason Glover, Managing Partner of the Firm’s London Office. “Along with our recent promotion of Étienne Renaudeau to Partner, we expect David, Antonio and Étienne to spearhead the future growth of our European antitrust practice.”

Antonio joins the Firm from Allen & Overy LLP, where he was Co-Head of the Global Antitrust Practice and Co-Head of the Telecoms, Media and Technology Practice. He is both U.K. and Italy-qualified. He received his J.D., magna cum laude, from the University of Florence and a Ph.D. from University College London, where he is a visiting professor and Co-Founder and Co-Director of the Jevons Institute for Competition Law and Economics. Antonio is also a non-governmental adviser on unilateral practices and merger control for the International Competition Network of competition authorities.

ABOUT SIMPSON THACHER

Simpson Thacher & Bartlett LLP (www.simpsonthacher.com) is one of the world’s leading international law firms. The Firm was established in 1884 and has more than 1,000 lawyers. Headquartered in New York with offices in Beijing, Hong Kong, Houston, London, Los Angeles, Palo Alto, São Paulo, Tokyo and Washington, D.C., the Firm provides coordinated legal advice and transactional capability to clients around the globe.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media:
Caroline Fatchett
Simpson Thacher
Assoc. Director, Communications
Caroline.Fatchett@stblaw.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Mary Kay Introduces the K-Beauty Texture Edit5.10.2026 15:02:00 EEST | Press release

Mary Kay Inc.,the iconic beauty giant announced today the launch of the K-Beauty Texture Edit, aspecial-edition skin care collection available while supplies last. The collection builds on the momentum of the company's largest consumer-facing global brand platform, Beauty Is More Beautiful Shared™ which launched in September. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261005600130/en/ Mary Kay's Special Edition K-Beauty Texture Edit is a trend-forward collection which includes three Korea-made products: the Mary Kay® Melt-In Cleansing Balm, Mary Kay® Snail Gel Face Patches and Mary Kay® Collagen Moisturizing Gel. (Image Credit: Mary Kay Inc.) Inspired by Korea's globally influential skin care and self-care philosophy designed to bring playful textures, innovative ingredients, and elevated beauty experiences, the K-Beauty Texture Editwas designed to resonate with a global cultural beauty movement captivating the next gene

GE HealthCare to Acquire SOFIE Biosciences, Establishing a 'Final Mile' Footprint for PET Radiopharmaceutical Supply in the U.S.5.10.2026 15:00:00 EEST | Press release

GE HealthCare (Nasdaq: GEHC) today announced a definitive agreement to acquire SOFIE Biosciences, a leading U.S.-based CMO for PET radiopharmaceuticals, from Trilantic North America, for a purchase price of $945 million paid in cash. The transaction is expected to close in the first half of 2027, subject to closing conditions, including regulatory approvals, at which time SOFIE Biosciences will become part of GE HealthCare’s PDx segment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261005273717/en/ SOFIE Biosciences has 15 CMO sites across the U.S., manufacturing PET radiopharmaceutical products The acquisition of SOFIE Biosciences establishes a footprint for GE HealthCare in the time-critical ‘final mile’ of U.S. PET radiopharmaceutical supply, while also enabling PDx to participate in other high growth areas outside its own product portfolio. With a U.S. network of 15 CMO sites operating 21 cyclotrons, and a theranostics

Henkell Freixenet Strengthens Premium Dealcoholized Sparkling Wine Production with Solos' Patented Aroma Recovery System5.10.2026 14:24:00 EEST | Press release

Henkell Freixenet is expanding its premium dealcoholized sparkling wine production capabilities through the deployment of Solos Technology's patented Aroma Recovery System (ARS) at its Wiesbaden production site, the Group’s expertise centre for alcohol-free production. The installation represents a significant investment in next-generation dealcoholized sparkling wine production, helping preserve the natural aroma and sensory identity of the original wines. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261005959301/en/ Fürst von Metternich Riesling Alcohol-free on the bottling line, one of the first products in Henkell Freixenet’s portfolio developed in collaboration with Solos Technology. The project combines Henkell Freixenet's longstanding winemaking expertise with Solos' proprietary dealcoholization and patented aroma recovery technology. With 30 years of experience in producing alcohol-free sparkling wines, Henkell Fre

Croma-Pharma Expands Its Portfolio in Canada With saypha ® lips Lidocaine and Exprecell™5.10.2026 14:12:00 EEST | Press release

Croma-Pharma continues to build its portfolio in Canada, adding saypha® lips Lidocaine, a hyaluronic acid filler for lip augmentation,1 and Exprecell™, a medical device for the preparation of autologous PRP | Fluid-PRF.2 Both are distributed by Renellence, Croma's partner in Canada since 2025. The two additions reflect Croma's broader approach: pairing established hyaluronic acid expertise with autologous, regenerative technologies. Together, they give practitioners options across both aesthetic and regenerative treatment categories, from a single trusted source. "With saypha® lips Lidocaine and Exprecell™, we're giving Canadian practitioners a wider set of tools for facial aesthetics and regenerative treatments, each held to the same standard of precision and safety," said Andreas Prinz, Chief Executive Officer of Croma-Pharma GmbH. Renellence has distributed Croma's Saypha® hyaluronic acid filler range in Canada since October 2025, alongside medical education and training for Canadia

Anaeco Secures Strategic Investment from Momentum Global Ventures to Accelerate Commercial Deployment5.10.2026 13:00:00 EEST | Press release

Anaeco, Inc., a clean technology company developing systems to destroy harmful and difficult-to-abate gases, today announced a strategic investment from Momentum Global Ventures. The investment supports Anaeco as it moves from technology development and validation to commercial deployment across three initial markets: anesthetic gases, refrigerants, and semiconductor manufacturing. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261005546122/en/ Anaeco’s technology exploits atmospheric chemistry to destroy harmful, high-impact gases, including HFCs, PFAS, anesthetic gases, N2O, and other difficult-to-abate emissions at their source. By accelerating processes that naturally transform pollutants, its modular technology provides a practical, scalable approach to emissions that are difficult or costly to manage conventionally. Initial Commercial Verticals Anesthetics: Destroying anesthetic gases generated in healthcare environmen

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye